DEF: Accuray Sets 2025 Annual Meeting Agenda, Seeks Equity Plan Approval

Accuray Incorporated announced its 2025 Annual Meeting of Stockholders will be held virtually on November 13, 2025, to vote on director elections, a new equity incentive plan, executive compensation, and auditor ratification.

Summary

• The 2025 Annual Meeting of Stockholders will be held virtually via live audio webcast on Thursday, November 13, 2025, at 9:00 a.m. PST.
• Stockholders will vote on the election of three Class I directors, approval of the 2026 Equity Incentive Plan, an advisory vote to approve the compensation of named executive officers, and ratification of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
• The proposed 2026 Equity Incentive Plan seeks to reserve 3,896,000 new shares for issuance, in addition to certain shares from the existing 2016 Plan, to attract, motivate, and retain key personnel.
• Fiscal year 2025 financial results were mixed: revenue reached $459 million (87% of target), orders (net of cancellations) were $288 million (97% of target), and adjusted EBITDA (excluding bonus accrual) was $28.8 million (65% of target).
• No cash incentive awards were paid for fiscal year 2025 to named executive officers due to below-threshold performance against corporate objectives and considerations for debt covenant compliance and cash conservation.
• Supplemental targeted cash incentives were paid to Suzanne Winter ($25,000), Ali Pervaiz ($50,000), and Sandeep Chalke ($25,000) for achieving specific initiatives.
• A transaction bonus of $50,000 was paid to Jesse Chew in recognition of his significant efforts in the company's debt refinancing.
• Robert C. Kill, a Class I director, is not standing for re-election, and Chan W. Galbato has been nominated for election as a Class I director.
• Steven F. Mayer was appointed to the Board in June 2025 in connection with the company's debt refinancing.
• Jesse Chew resigned from the company as Senior Vice President, Chief Legal Officer and Corporate Secretary, effective September 19, 2025.
• Leonel Peralta was appointed Senior Vice President, Chief Operations Officer in February 2025.

Sentiment

Score: 4

Explanation: The filing presents mixed financial results for fiscal year 2025, with key metrics like revenue, orders, and adjusted EBITDA falling below targets, leading to no cash incentive payouts for executives. However, it highlights strong corporate governance practices, a new equity incentive plan designed to attract and retain talent, and the successful completion of a debt refinancing. The resignation of a key executive adds a minor negative note.

Positives

• The company maintains sound corporate governance standards, including double-trigger equity acceleration, a clawback policy, stock ownership requirements, and an independent compensation consultant.
• The proposed 2026 Equity Incentive Plan incorporates corporate governance best practices such as no evergreen provision, no discounted stock options or stock appreciation rights, no repricing, minimum vesting requirements, and annual limits on non-employee director awards.
• A successful debt refinancing was completed in June 2025, which was a key performance goal for some executives.
• Stockholders demonstrated strong support for the executive compensation program with approximately 93.2% of votes cast in favor of the 2024 'Say-on-Pay' proposal.
• All named executive officers and non-employee directors are either in compliance with or on track to meet the company's stock ownership requirements.

Negatives

• Fiscal year 2025 financial results were mixed, with revenue ($459 million), orders ($288 million), and adjusted EBITDA ($28.8 million) falling below pre-established targets for the Company Bonus Plan.
• No cash incentive awards were paid to named executive officers for fiscal year 2025 due to below-threshold achievement of performance objectives and the need to reduce operating expenses and conserve cash.
• The company would not have been compliant with debt covenants in effect at the beginning of fiscal 2025, which influenced the decision not to pay cash incentives.
• Performance goals for Performance Stock Units (PSUs) granted in fiscal 2023, which were measured at the end of fiscal 2025, were not met, resulting in the cancellation of those shares.
• Robert C. Kill, a Class I director, is not standing for re-election, indicating a change in board composition.
• Jesse Chew, Senior Vice President, Chief Legal Officer and Corporate Secretary, resigned from the company effective September 19, 2025.

Risks

• Global supply chain challenges, inflation, and other global macroeconomic conditions and uncertainties pose risks to the company's performance.
• There is a risk of not attracting and retaining key talent if equity incentives are insufficient, particularly if the proposed 2026 Equity Incentive Plan is not approved.
• The Board oversees operational, financial, legal and regulatory, cybersecurity, strategic, and reputational risks.
• The company faced a risk of non-compliance with debt covenants at the beginning of fiscal 2025, which impacted compensation decisions.
• Cybersecurity threats and incidents are a critical part of risk management, with ongoing assessments and reporting to the Audit Committee and Board.

Future Outlook

The company expects the number of shares reserved for issuance under the 2026 Equity Incentive Plan to be sufficient for granting equity-based compensation at appropriate levels for at least the next year. The Compensation Committee will continue to analyze and adjust executive compensation policies and practices to reflect performance and competitive needs. The company is committed to maintaining or improving its level of stockholder engagement going forward.

Management Comments

• Our Board and management are committed to maintaining sound and effective compensation and governance programs, with policies and programs reflecting best practices and designed to build value for our stockholders.
• The Compensation Committee recognizes the importance of having on-going and open conversations with our stockholders to solicit their feedback.
• We value the insights gained from our discussion with our stockholders and find them to be helpful even when points of view vary.
• We believe that there should be a strong relationship between pay and performance, and our executive compensation program reflects this belief.
• The Compensation Committee believes that this combination of awards appropriately balances the various objectives of our long-term incentive compensation program because it promotes long-term value creation critical to driving stockholder value, directly aligns executive compensation with stockholder interests through share ownership, and encourages our key executive officers to remain engaged with our organization through the vesting date of the awards, which is typically a multi-year period.

Industry Context

The company operates in the technology, life sciences, and medical devices industries, competing for executive talent within this sector. Its compensation peer group for fiscal 2025 included 19 medical device companies with comparable financial and organizational characteristics. The company's executive compensation program aims to remain competitive within this highly competitive labor market.

Comparison to Industry Standards

• The company utilizes the Radford 2024 High-Tech Industry Survey and a Compensation Peer Group of 19 medical device companies to benchmark executive and non-employee director compensation. This peer group includes companies such as AngioDynamics, Inc., Inari Medical, Inc., Orthofix Medical Inc., Artivion, Inc., Inogen, Inc., RadNet, Inc., Avanos Medical, Inc., Inspire Medical Systems, Inc., Tactile Systems Technology, Inc., CONMED Corporation, iRhythm Technologies, Inc., Tandem Diabetes Care, Inc., Cue Health Inc., Lantheus Holdings, Inc., Varex Imaging Corporation, Cutera, Inc., Merit Medical Systems, Inc., Glaukos Corporation, and Nevro Corp.
• The company's compensation philosophy aims to set target incentive compensation opportunities near the market median and target total cash compensation opportunities above the market median, tied to challenging, pre-established corporate performance objectives.
• The non-employee director compensation program is assessed to generally align with competitive market practices, based on market data and analysis by Exequity LLP.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Will vote on key corporate governance matters including director elections, the new equity incentive plan, executive compensation, and auditor ratification. They face potential dilution from the new equity incentive plan, though it includes safeguards. The mixed financial results and absence of cash bonuses for executives may impact investor sentiment. The successful debt refinancing is a positive for financial stability.
• Employees: Are eligible for equity awards under the proposed 2026 Equity Incentive Plan, which is designed to attract and retain talent. However, no cash incentive awards were paid for fiscal year 2025.
• Management/Executives: Experienced mixed financial results leading to no cash incentive awards for fiscal 2025, but some received supplemental bonuses for specific achievements. They are subject to new clawback policies and stock ownership requirements. Changes in executive leadership and board composition may affect internal dynamics.
• Creditors: Benefited from the successful debt refinancing in June 2025, which addressed potential debt covenant non-compliance.

Next Steps

• Hold the 2025 Annual Meeting of Stockholders virtually on November 13, 2025.
• Stockholders will vote on the election of three Class I directors at the Annual Meeting.
• Stockholders will vote on the approval of the 2026 Equity Incentive Plan at the Annual Meeting.
• Stockholders will conduct an advisory vote to approve named executive officer compensation at the Annual Meeting.
• Stockholders will ratify the appointment of Grant Thornton LLP as the independent registered public accounting firm for fiscal year ending June 30, 2026, at the Annual Meeting.
• The Compensation Committee will continue to analyze and adjust executive compensation policies and practices to reflect performance and competitive needs.
• The company will continue to seek opportunities for dialogue with stockholders on executive compensation and other matters on an ongoing basis.
• Publish final voting results in a Current Report on Form 8-K filed with the SEC within four business days following the Annual Meeting.

Key Dates

Recommendation

The company reported mixed financial results for fiscal year 2025, with key performance indicators falling below targets, leading to no cash incentive payouts for executives. This indicates operational challenges. However, the successful debt refinancing and the proposal of a new equity incentive plan with strong governance features suggest efforts to stabilize and incentivize future growth. The changes in executive leadership and board composition, while potentially disruptive, could also signal a strategic pivot. Given the current operational underperformance balanced by proactive governance and financial restructuring, a 'hold' recommendation is appropriate, awaiting clearer signs of improved financial execution and the impact of the new strategic initiatives.

Keywords

SEC filing, Proxy Statement, Annual Meeting, Accuray Incorporated, ARAY, Corporate Governance, Executive Compensation, Equity Incentive Plan, Director Election, Auditor Ratification, Financial Performance, Debt Refinancing, Medical Devices, Healthcare Technology, Stockholder Vote, Risk Management, Compensation Committee, Board of Directors